Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.

British journal of pharmacology·2006
Same author

Linking age-related changes in skeletal muscle mass and composition with metabolism and disease.

The journal of nutrition, health & aging·2006
Same author

Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.

Journal of psychiatric practice·2005
Same author

Advances in the application of imaging methods in applied and clinical physiology.

Acta diabetologica·2003
Same author

Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.

Gene therapy·2003
Same author

Cardiorespiratory fitness is associated with diminished total and abdominal obesity independent of body mass index.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
Same journal

The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

Journal of cardiovascular pharmacology·2026
Same journal

Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.

Journal of cardiovascular pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

Atherosclerosis.

R Ross

    Journal of Cardiovascular Pharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Atherosclerosis involves smooth muscle lesions caused by endothelial injury. Preventing these lesions requires protecting the endothelium and inhibiting platelet interactions and growth factor activity.

    More Related Videos

    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
    09:55

    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

    Published on: October 25, 2024

    Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
    09:09

    Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

    Published on: April 3, 2026

    Related Experiment Videos

    Last Updated: Jun 25, 2026

    Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
    06:43

    Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

    Published on: December 7, 2013

    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
    09:55

    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

    Published on: October 25, 2024

    Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
    09:09

    Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

    Published on: April 3, 2026

    Area of Science:

    • Cardiovascular Research
    • Cell Biology
    • Pathology

    Background:

    • Atherosclerosis is characterized by proliferative smooth muscle lesions.
    • These lesions stem from endothelial injury or dysfunction linked to atherosclerosis risk factors.

    Purpose of the Study:

    • To outline strategies for preventing atherosclerotic lesion development.
    • To highlight the role of endothelial protection, platelet inhibition, and growth factor modulation.

    Main Methods:

    • Review of existing research on atherosclerosis pathogenesis.
    • Analysis of cellular interactions (platelets, macrophages) and growth factor involvement.

    Main Results:

    • Endothelial injury is a key initiator of smooth muscle proliferation.
    • Interactions between platelets, macrophages, and released growth factors contribute to lesion formation.

    Conclusions:

    • Preventative strategies must focus on maintaining endothelial integrity and its non-thrombogenic properties.
    • Inhibiting platelet interactions and understanding/blocking growth factor activity are crucial for lesion prevention.